A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
about
Fatigue in systemic lupus erythematosus.IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy.Some controversies of neuropsychiatric systemic lupus erythematosus.
P2860
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
@en
type
label
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
@en
prefLabel
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
@en
P2093
P356
P1476
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
@en
P2093
C Pellegrino
G L Clayman
S M Lippman
S P Schantz
P2888
P304
P356
10.1007/BF00877250
P577
1992-08-01T00:00:00Z
P6179
1048697821